InsidersTradesSigma
Browse the detailed record of transactions filed by STARKS DANIEL J, Director. Director active across 1 companies, notably Abbott Laboratories. In total, 2 filings have been published. Total volume traded: €1.8m. The latest transaction was disclosed on 3 May 2022 — Cession. Regulator: SEC (Form 4). The full history is openly available.
2 of 2 declarations
Daniel J. Starks is a board member of Abbott Laboratories. In this role, he participates in the governance of the company and in strategic decision-making. His expertise is valuable for the development of the organization.